Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Share:
Related VRX
Valeant Hits Highest Level In 4 Months
Mid-Afternoon Market Update: Steelcase Tumbles Following Disappointing Earnings Report; Staples Shares Surge
Related GLW
Watch These 8 Huge Call Purchases In Friday Trade
Benzinga's Option Alert Recap From May 25

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: Mad MoneyCNBC Jim Cramer Media

 

Related Articles (GLW + SGYP)

View Comments and Join the Discussion!